At5g22100 Antibody

Absence in Major Antibody Databases

• The commercial antibody catalog from Cusabio (Source 6) lists 64 Arabidopsis thaliana antibodies targeting gene loci such as At2g45640, At1g04770, and At5g26760, but no entry exists for At5g22100 .

• Similarly, R&D Systems’ antibody catalog (Source 2) focuses on ATG5 antibodies for human, mouse, and rat homologs, with no Arabidopsis-specific antibodies listed .

Lack of Published Research

• A review of antibody characterization studies (Source 3) and proteomics research (Source 4) revealed no references to At5g22100 in Arabidopsis or other model organisms .

• High-impact journals like eLife and PLOS ONE (Sources 3, 5) include detailed antibody validation workflows but do not mention this target .

Potential Explanations for the Gap

• Gene Function: At5g22100 may encode a hypothetical or poorly characterized protein in Arabidopsis, reducing demand for antibody development.

• Technical Challenges: Antibody generation against highly conserved or low-abundance antigens often requires specialized methods (e.g., recombinant protein expression), as noted in Source 5 for TNF-alpha antibodies .

• Commercial Viability: Antibody vendors prioritize targets with established research or therapeutic relevance (Source 8), which may exclude At5g22100 .

Recommendations for Future Research

To address this gap, researchers should:

1. Validate Gene Expression: Confirm At5g22100’s expression in Arabidopsis tissues using RNA-seq or proteomics.

2. Collaborate with Vendors: Request custom antibody development (e.g., Cusabio’s services) .

3. Utilize KO Models: Generate Arabidopsis knockout lines to study At5g22100’s biological role and antibody specificity, following protocols in Source 3 .